Hepatocyte viability and protein expression within hydrogel microstructures
- PMID: 15932275
- DOI: 10.1021/bp049681i
Hepatocyte viability and protein expression within hydrogel microstructures
Abstract
Poly(ethylene) glycol (PEG) hydrogels have been successfully used to entrap mammalian cells for potential high throughput drug screening and biosensing applications. To determine the influence of PEG composition on the production of cellular protein, mammalian hepatocytes were maintained in PEG hydrogels for 7 days. Total cell viability, total protein production, and the production of two specific proteins, albumin and fibronectin, were monitored. Studies revealed that while PEG composition has no effect on cell viability, increasing amounts of PEG in the hydrogel decrease the amount of protein production by the cells after 7 days from 1.0 x 10(5) +/- 1.7 x 10(4) to 5.2 x 10(3) +/- 1.3 x 10(3) g accumulated protein/mL/million cells. Additionally, cells entrapped in PEG hydrogels produce greater amounts of protein than traditional monolayer culture (1.5 x 10(3) +/- 1.9 x 10(2) g accumulated protein/mL/million cells after 7 days). The addition of the synthetic peptide RGD to 10% PEG hydrogels altered the production of the proteins albumin and fibronectin. Hydrogels with the RGD sequence produced 287 +/- 27 ng/mL/million cells albumin after 7 days, an order of magnitude greater than monolayer cultures, whereas cells in hydrogels without the RGD sequence produced undetectable levels of albumin. Conversely, cells entrapped in 10% PEG hydrogels without the RGD sequence produced 1014 +/- 328 ng/mL/million cells fibronectin after 7 days, whereas 10% PEG hydrogels with the RGD sequence produced 200 +/- 58 ng/mL/million cells fibronectin after 7 days.
Similar articles
-
Assessment of hepatocellular function within PEG hydrogels.Biomaterials. 2007 Jan;28(2):256-70. doi: 10.1016/j.biomaterials.2006.08.043. Epub 2006 Sep 18. Biomaterials. 2007. PMID: 16979755
-
Cryopreservation of cell-containing poly(ethylene) glycol hydrogel microarrays.Biotechnol Prog. 2005 May-Jun;21(3):1004-7. doi: 10.1021/bp049551+. Biotechnol Prog. 2005. PMID: 15932288
-
Viral infection of human progenitor and liver-derived cells encapsulated in three-dimensional PEG-based hydrogel.Biomed Mater. 2009 Feb;4(1):011001. doi: 10.1088/1748-6041/25/1/011001. Epub 2008 Nov 4. Biomed Mater. 2009. PMID: 18981544
-
Hydrogels for in vivo-like three-dimensional cellular studies.Wiley Interdiscip Rev Syst Biol Med. 2012 Jul-Aug;4(4):351-65. doi: 10.1002/wsbm.1174. Epub 2012 May 21. Wiley Interdiscip Rev Syst Biol Med. 2012. PMID: 22615143 Review.
-
Hydrogels: their future, Part II.Med Device Technol. 1998 Apr;9(3):22-5. Med Device Technol. 1998. PMID: 10179196 Review.
Cited by
-
Encapsulation of Biological Agents in Hydrogels for Therapeutic Applications.Gels. 2018 Jul 11;4(3):61. doi: 10.3390/gels4030061. Gels. 2018. PMID: 30674837 Free PMC article. Review.
-
Cell and tissue engineering for liver disease.Sci Transl Med. 2014 Jul 16;6(245):245sr2. doi: 10.1126/scitranslmed.3005975. Sci Transl Med. 2014. PMID: 25031271 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources